the effectiveness of the intermittent treatment ( 2/7 ) with rifampicin + etambutol , administered over periods of 3 to 24 months , was tested in a log of 229 out-patients suffering from tuberculosis ( bacilli carriers ) .
C0035608
rifampicin
C0041296
tuberculosis